Profile picture

Professor Jason Dyck

(Canada)
Follow
Logo ESC

Contributor content

Remembering Dr Gary D. Lopaschuk, PhD (1956–2025)
Journal
Remembering Dr Gary D. Lopaschuk, PhD (1956–2025)
20 November 2025
Read more
Ketone therapy prevents semaglutide-induced loss of cardiac mass
Journal
Ketone therapy prevents semaglutide-induced loss of cardiac mass
30 September 2025
Read more
Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart
Journal
Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart
18 January 2025
Read more
Ketone therapy for heart failure: current evidence for clinical use
Journal
Ketone therapy for heart failure: current evidence for clinical use
11 March 2021
Read more
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes
Journal
Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes
6 April 2018
Read more
Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression
Journal
Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression
10 March 2016
Read more
AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism
Journal
AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism
28 May 2015
Read more

ESC 365 is supported by

novartis Explore sponsored resources